李双,王炳杰,陶娇娇,等.基于化学动力疗法的海藻酸钠中空硫化铜载药水凝胶抗乳腺癌研究[J].中国海洋药物,2025,44(4):20-28.
基于化学动力疗法的海藻酸钠中空硫化铜载药水凝胶抗乳腺癌研究
Sodium alginate hollow copper sulfide drug-loading hydrogel based on chemodynamic therapy for anti-breast cancer research
投稿时间:2024-03-26  修订日期:2024-05-07
DOI:10.13400/j.cnki.cjmd.2025.04.001
中文关键词:  海藻酸钠  中空硫化铜  双氢青蒿素  柳氮磺吡啶  化学动力疗法
English Keywords:sodium alginate  hollow copper sulfide  dihydroartemisinin  sulfasalazine  chemodynamic therapy  ferroptosis
Fund Project:
作者单位E-mail
李双 中国海洋大学 海洋药物教育部重点实验室 3350481625@qq.com 
王炳杰 中国海洋大学 海洋药物教育部重点实验室 wbj6542@163.com 
陶娇娇 中国海洋大学 海洋药物教育部重点实验室 tjj2892@stu.ouc.edu.cn 
董雨 中国海洋大学 海洋药物教育部重点实验室 3473876404@qq.com 
蒋天泽* 中国海洋大学 海洋药物教育部重点实验室 jiangtianze@ouc.edu.cn 
赵峡 中国海洋大学 海洋药物教育部重点实验室 zhaoxia@ouc.edu.cn 
摘要点击次数: 1055
全文下载次数: 1
中文摘要:
      目的 制备一种共载双氢青蒿素(DHA)和柳氮磺吡啶(SAS)的海藻酸钠中空硫化铜(HCuS)载药水凝胶,并研究其抗肿瘤活性。方法 采用模板法制备HCuS,利用搅拌吸附法制备共载DHA和SAS的载药HCuS(DSHC),通过海藻酸钠(SA)和泊洛沙姆407(F127)物理交联包载DSHC制备可注射温敏水凝胶(DSHC-Gel)。结果 该水凝胶能响应肿瘤微环境的低pH释放铜离子(Cu2+)、DHA和SAS。Cu2+可通过类芬顿反应消耗过氧化氢(H2O2),产生活性氧(ROS)实现肿瘤化学动力学疗法(CDT);DHA的过氧桥可被细胞内的Fe2+裂解产生ROS,缓解H2O2不足;SAS可靶向溶质载体家族7成员11(SLC7A11)来抑制谷胱甘肽(GSH)的合成。CDT联用DHA和SAS共同改善H2O2浓度不足和GSH水平过高导致的ROS生成不足问题。结果表明,DSHC-Gel在体外能显著抑制乳腺癌4T1细胞的生长。结论 通过同时缓解H2O2不足和降低GSH合成的策略为增强CDT抗肿瘤效果提供了新的思路。
English Summary:
      Objective To prepare sodium alginate hollow copper sulfide (HCuS) hydrogel loaded with dihydroartemisinin (DHA) and sulfasalazine (SAS), and to study its anti-tumor activity. Methods HCuS was prepared by template method, and drug loaded nanoparticles (DSHC) encapsulating dihydroartemisinin (DHA) and sulfasalazine (SAS) was prepared by stirring adsorption. The injectable thermosensitive hydrogel (DSHC-Gel) was prepared by physical crosslinking of sodium alginate (SA) and poloxamer 407 (F127) with DSHC. Results The hydrogel released copper ion (Cu2+), DHA and SAS under acidic tumor microenvironment. Cu2+ consumed hydrogen peroxide (H2O2) and generate reactive oxygen species (ROS) by Fenton-like reaction to achieve tumor chemodynamic therapy (CDT). DHA with peroxide bridge was cleaved by intracellular Fe2+ to generate ROS to alleviate H2O2 deficiency. SAS inhibited glutathione (GSH) synthesis by targeting solute carrier family 7 members 11 (SLC7A11). CDT combined with DHA and SAS improved low ROS generation collectively caused by H2O2 deficiency and high GSH levels. The results showed that DSHC-Gel significantly inhibited the growth of 4T1 cells in vitro. Conclusion The strategy of increasing H2O2 supply and decreasing GSH synthesis simultaneously provides a novel approach to enhance the anti-tumor effect of CDT.
查看全文  查看/发表评论  下载PDF阅读器
关闭